Related Experiment Video
Updated: Jun 24, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
Device safety and effectiveness in the pediatric population: a US FDA perspective
Joy Samuels-Reid1, Judith U Cope, Audrey E Morrison
1Division of Anesthesiology, General Hospital, Infection Control and Dental Devices, Center for Devices and Radiological Health, Office of Device Evaluation, FDA, Rockville, MD 20857, USA. joy.samuels-reid@fda.hhs.gov
Insights
Ensuring safe pediatric medical device use requires educating healthcare providers and manufacturers about unique risks. Heightened awareness of differing adverse events and risk mitigation strategies is crucial for child safety.
Area of Science:
- Pediatric medical device safety and regulation
- Healthcare quality improvement
- Adverse event monitoring in pediatrics
Background:
- The U.S. Food and Drug Administration (FDA) acknowledges significant challenges in the safe and responsible use of medical devices in children.
- Effective education for manufacturers and healthcare providers is essential for addressing pediatric-specific medical device issues.
- Adverse events and risk mitigation strategies for medical devices can differ significantly between adult and pediatric populations, including within pediatric subpopulations.
Purpose of the Study:
- To highlight the importance of education for manufacturers and healthcare providers regarding pediatric medical device safety.
- To emphasize the unique challenges and considerations for medical device use in the pediatric population.
- To underscore the need for recognizing and addressing differences in adverse events and risk mitigation for pediatric subpopulations.
Main Methods:
- Review of FDA perspectives on pediatric medical device challenges.
- Analysis of the role of education in medical device safety.
- Discussion of the differences in adverse events and risk mitigation between adult and pediatric populations.
Main Results:
- Medical device safety in children faces unique hurdles.
- Education is a critical component for safe pediatric device use.
- Adverse events and risk mitigation strategies vary across pediatric groups.
Conclusions:
- Manufacturers and healthcare providers must be aware of pediatric-specific medical device issues.
- Recognizing differing adverse events and risk mitigation is key to reducing harm.
- Increased awareness promotes the safe and effective use of medical devices in children.
Abstract:
The US FDA recognizes that there are many challenges to ensuring that medical devices are used responsibly and safely in the pediatric population. Education plays a key role, and manufacturers and healthcare providers must be informed of medical device issues unique to the pediatric population. Healthcare workers and device manufacturers must recognize that adverse events may differ between the adult and pediatric population and among pediatric subpopulations. Risk mitigation may also differ, and heightened awareness will reduce the potential for adverse events and promote the safe use of medical devices in children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Regulation
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
